Raiffeisen Bank International’s Evolent Health EVH Stock Holding History

Raiffeisen Bank International’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-150,000	Closed	-$608K	–	836
2025 Q4	$608K	Hold	150,000	–	–	0.01%	418
2025 Q3	$1.32M	Buy	150,000 +10,000	+7%	+$97K	0.02%	289
2025 Q2	$1.5M	Buy	140,000 +20,000	+17%	+$184K	0.02%	236
2025 Q1	$1.15M	Buy	120,000 +30,000	+33%	+$303K	0.02%	266
2024 Q4	$988K	Buy	+90,000	New	+$1.58M	0.02%	273

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raiffeisen Bank International's EVH Position: Q1 2026 in Review

Raiffeisen Bank International sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 150,000 shares — an estimated $608K sold.

Raiffeisen Bank International first reported a position in EVH in Q4 2024 and held it in 5 quarters. The position peaked at $1.5M in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Raiffeisen Bank International reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
Raiffeisen Bank International sold 150,000 Evolent Health shares in Q1 2026, an estimated $608K.
Raiffeisen Bank International first reported a position in Evolent Health in Q4 2024 and held it in 5 quarters.
Raiffeisen Bank International's Evolent Health position peaked at $1.5M in Q2 2025.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.